FDA Approves New Therapy for HRR-Mutated Prostate Cancer
Welcome to Onco Life Centre Podcast. This episode explains how the FDA's October 26, 2026 decision opens an existing two-drug combination to earlier use in metastatic prostate cancer with homologous recombination repair gene mutations. We walk through who qualifies, what the trial found, and which risks matter. You'll learn: - What the FDA decision on October 26, 2026 changed for metastatic prostate cancer - Who qualifies, including the cancer stage terms and the HRR gene mutation requireme...
You May Also Like

The Newest Olympian
Mike Schubert

RISK!
Kevin Allison

Tony Katz Today
Tony Katz

The Splendid Table: Conversations & Recipes For Curious Cooks & Eaters
American Public Media

Mahlakung
Thobela FM

The Losers' Club: A Stephen King Podcast
Bloody FM
War Nerd Radio — Subscriber Feed
Gary Brecher

The Sporkful
Dan Pashman

Magellans at the Movies
Nathan Magalhaes

Podcast Patapoe
0d0a
Community discussion